Neurocrine Biosciences (NBIX) Intangibles (2022 - 2026)
Neurocrine Biosciences (NBIX) recorded Intangibles of $2.23 billion in Q2 2026, compared with $37.2 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Intangibles (2022 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences reported Intangibles of $4.7 million, down 87.1% from FY2024.
- Annual Intangibles has a three-year compound annual growth rate of -49.8% (FY2022 to FY2025).
- Across earlier years, Intangibles came in at $36.5 million in FY2024 (+2.8%), $35.5 million in FY2023 (-4.6%) and $37.2 million in FY2022.
- The Q2 2026 figure is the highest quarterly Intangibles in data going back to Q4 2022.
- On a year-over-year basis, Intangibles rose in four of the last six quarters, with an average decline of 10.8%.
- Peak year-over-year performance for Intangibles in the last five years was growth of 11.0% in Q2 2025, against a decline of 87.1% in Q4 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Neurocrine Biosciences | 14.56 Bn | 10.26 Bn | 935.80 Mn | 2.23 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Bn |
| Dec 31, 2025 | 4.70 Mn |
| Sep 30, 2025 | 35.70 Mn |
| Jun 30, 2025 | 37.20 Mn |
| Mar 31, 2025 | 36.40 Mn |
| Dec 31, 2024 | 36.50 Mn |
| Sep 30, 2024 | 34.50 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 34.30 Mn |
| Dec 31, 2023 | 35.50 Mn |
| Sep 30, 2023 | 34.90 Mn |
| Jun 30, 2023 | 36.90 Mn |
| Mar 31, 2023 | 37.20 Mn |
| Dec 31, 2022 | 37.20 Mn |
API Access
Neurocrine Biosciences Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();